So at Sunesis, we're a well-capitalized company with an experienced team and our development efforts are focused on vosaroxin, which is a unique cancer therapeutics to which we have worldwide commercial rights.

SOUTH SAN FRANCISCO, Calif., May 10, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that the Company will present at two upcoming investor conferences.

SOUTH SAN FRANCISCO, Calif., April 24, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will be presenting at the Needham & Company 12th Annual ...

SOUTH SAN FRANCISCO, Calif., May 2, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that it will host a conference call on Thursday, May 9, 2013 at 11:00 a.m.

Vote up. loading. (RTTNews.com) - Sunesis Pharmaceuticals Inc.( SNSS ) will present at the UBS Global Healthcare Conference in Sheraton Hotel, New York City.

Vote up. loading. (RTTNews.com) - Sunesis Pharmaceuticals Inc.( SNSS ) will present at the Bank of America Merrill Lynch Health Care Conference in Las Vegas.

Vote up. loading. (RTTNews.com) - Sunesis Pharmaceuticals Inc. ( SNSS ) will present at the Needham & Company 12th Annual Healthcare Conference in New York City.

0.36 3 -0.03 09 May AMC Q1 2013 Stifel Financial 0.57 7 0.55 09 May AMC Q1 2013 Salix Pharmaceuticals Inc 0.68 16 0.67 09 May BMO Q1 2013 Sunesis Pharmaceuticals, Inc. -0.20 8 -0.30 09 May BMO Q2 2013 Suburban Propane Partners 2.53 9 1.38 09 ...

The figures are provided by Thomson Reuters I/B/E/S. **** Company Name Ticker Qtr Industry Curr EPS Est EPS Act Diff EPS Rev Est Rev Act Diff Rev 51JOB INC Q1 INDUSTRIAL SERVICES USD 0.62 0.59 -0.03 61.2 61.2 0.0 AAON INC Q1 BUILDING ..... -0.20 700.2 ...